Pharmaceutical development

About Novartis Pharmaceutical Development

Novartis Pharmaceutical Development is responsible for taking innovative drug candidates from the Novartis Institutes for BioMedical Research – or from licensing partners – and proving them to be safe, effective, high-quality therapies with superior value to patients. We currently have approximately 140 projects in our Pharmaceuticals pipeline.

 

Novartis Pharmaceutical Development organisation

Development at Novartis is truly a worldwide endeavour. Our key development facilities are in the following locations:

• Basel (Switzerland)
• East Hanover, New Jersey and Cambridge, Massachusetts (US)
• Horsham (UK)
• Hyderabad (India)
• Shanghai and Changshu (China)
• Tokyo (Japan) and
• Rueil (France)

More than 8500 associates work for Novartis Pharmaceutical Development.